Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 343

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Cannabidiol for the Reduction of Cue-Induced Craving and Anxiety in Drug-Abstinent Individuals With Heroin Use Disorder: A Double-Blind Randomized Placebo-Controlled Trial

Hurd, Yasmin L., Spriggs, Sharron, Alishayev, Julia, Winkel, Gary, Gurgov, Kristina, Kudrich, Chris, Oprescu, Anna M., Salsitz, Edwin·2019·American Journal of Psychiatry

Abstract

OBJECTIVE: Despite the staggering consequences of the opioid epidemic, limited nonopioid medication options have been developed to treat this medical and public health crisis. This study investigated the potential of cannabidiol (CBD), a nonintoxicating phytocannabinoid, to reduce cue-induced craving and anxiety, two critical features of addiction that often contribute to relapse and continued drug use, in drug-abstinent individuals with heroin use disorder. METHODS: This exploratory double-blind randomized placebo-controlled trial assessed the acute (1 hour, 2 hours, and 24 hours), short-term (3 consecutive days), and protracted (7 days after the last of three consecutive daily administrations) effects of CBD administration (400 or 800 mg, once daily for 3 consecutive days) on drug cue-induced craving and anxiety in drug-abstinent individuals with heroin use disorder. Secondary measures assessed participants' positive and negative affect, cognition, and physiological status. RESULTS: Acute CBD administration, in contrast to placebo, significantly reduced both craving and anxiety induced by the presentation of salient drug cues compared with neutral cues. CBD also showed significant protracted effects on these measures 7 days after the final short-term (3-day) CBD exposure. In addition, CBD reduced the drug cue-induced physiological measures of heart rate and salivary cortisol levels. There were no significant effects on cognition, and there were no serious adverse effects. CONCLUSIONS: CBD's potential to reduce cue-induced craving and anxiety provides a strong basis for further investigation of this phytocannabinoid as a treatment option for opioid use disorder.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1176/appi.ajp.2019.18101191

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 15 references

Research works printed but not linked: 22

  1. 10.1097/ADM.0000000000000412 · doi:10.1097/adm.0000000000000412
  2. 10.3949/ccjm.84a.16091 · DOI
  3. 10.1007/s11920-017-0783-9 · DOI · Paper page
  4. 10.2105/AJPH.2015.302664 · DOI · Paper page
  5. 10.1016/j.drugalcdep.2016.10.015 · DOI · Paper page
  6. 10.1097/ADM.0000000000000118 · DOI
  7. 10.1007/s13311-015-0373-7 · DOI · Paper page
  8. 10.1016/j.drugalcdep.2016.11.030 · DOI
  9. 10.1111/adb.12495 · DOI
  10. 10.1007/s40263-018-0578-5 · DOI · Paper page
  11. 10.1111/bph.12735 · DOI
  12. 10.1037/1064-1297.15.2.134 · DOI · Paper page
  13. 10.1111/add.14243 · DOI
  14. 10.1038/sj.npp.1300340 · DOI · Paper page
  15. 10.1111/ajad.12344 · DOI · Paper page
  16. 10.1038/s41386-018-0050-8 · DOI
  17. 10.1111/j.1360-0443.2006.01498.x · DOI · Paper page
  18. 10.1016/j.neuropharm.2018.03.001 · DOI · Paper page
  19. 10.1016/j.biopsych.2013.10.019 · DOI
  20. 10.1038/s41598-018-25846-2 · DOI
  21. 10.1089/can.2015.0004 · DOI
  22. 10.1089/can.2017.0009 · DOI · Paper page

Cited by

See all 343

Metadata

Authors
Hurd, Y. L., Spriggs, S., Alishayev, J., Winkel, G., Gurgov, K., Kudrich, C., Oprescu, A. M., & Salsitz, E.
Venue
American Journal of Psychiatry
Published
2019-11-01
Volume
176
Issue
11
Pages
911-922
ISSN
  • 0002-953X (ISSN-L)
  • 1535-7228
OpenAlex
W2946027664
Cited by
343
References
15
FWCI
24.80
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cannabidiol for the Reduction of Cue-Induced Craving and Anxiety in Drug-Abstinent Individuals With Heroin Use Disorder: A Double-Blind Randomized Placebo-Controlled Trial. https://app.cochat.ai/papers/10.1176/appi.ajp.2019.18101191
The paper
Hurd, Y. L., Spriggs, S., Alishayev, J., Winkel, G., Gurgov, K., Kudrich, C., Oprescu, A. M., & Salsitz, E. (2019). Cannabidiol for the Reduction of Cue-Induced Craving and Anxiety in Drug-Abstinent Individuals With Heroin Use Disorder: A Double-Blind Randomized Placebo-Controlled Trial. American Journal of Psychiatry. https://doi.org/10.1176/appi.ajp.2019.18101191

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.